Moreover, our results showed the correlation between TIGIT+CD4+ T cells and clinical inflammatory indicators, suggesting that TIGIT+CD4+ T cells may be used as an indicator to predict the occurrence and development of HBV-HCC. This evidence concerns the gene TIGIT and hepatocellular carcinoma.